Dr. Masao Murakami

Chairman
Southern TOHOKU Proton Therapy Center

Conventional radiotherapy for cancers may not protect normal cells while irradiating tumor cells. However, the most advantage and benefit of Proton Beam Therapy (PBT) is that PBT can precisely target tumors and minimize the damage to surrounding healthy cells.

Southern TOHOKU Proton Therapy Center is an integral part of our group’s affiliated Southern TOHOKU General Hospital. PBT in combination with concurrent chemotherapy seems to be more patient-friendly and expands an effort to improve cure and survival rates.

PBT becomes a mainstream cancer treatment option in future. Southern TOHOKU Hospital Group aims to achieve the mission of “excellence Japan for your health and hope” by means of available resources under the Group. Our PBT Center is committed to achieving our goal of “cure for not only cancers without surgical intervention, but also inoperable cancers.” We strive toward our vision of “exertion of profound influence on PBT clinical and research from Koriyama to the world.”
 

Printer Friendly